Clinical Trial Update: A Pilot Study of Eribulin in Breast Cancer (BC) Patients With Brain Metastases Previously Treated With Anthracyclines and Taxanes [Phase 2]

View source ↗

Summary

An update on a Phase 2 pilot trial evaluating eribulin in breast cancer patients with brain metastases who have previously received anthracyclines and taxanes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Halaven (eribulin)

Snippet

Sponsor: Tan Tock Seng Hospital | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN